Friday, July 31, 2026

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

North Korea Upgrades Airport Near Mount Paekdu as Tourism Push Gains Momentum

North Korea is upgrading Samjiyon Airport for international tourism, aiming to boost access to Mount Paekdu and enhance tourism infrastructure.

Samsung Heavy Industries Integrates SAVER Wind(C) to Revolutionize Container Ship Efficiency

Samsung Heavy Industries has delivered a 15,000 TEU container ship featuring the SAVER Wind(C) device, enhancing fuel efficiency by 6%.

Tag: Mellanox acquisition

No posts to display

Top News

- Our Sponsors Ad -

Follow us